CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,717 | -51.2% | 62,900 | -37.2% | 0.00% | – |
| Q2 2023 | $112,112 | -7.2% | 100,100 | -13.9% | 0.00% | – |
| Q1 2023 | $120,848 | -35.8% | 116,200 | -30.8% | 0.00% | -100.0% |
| Q4 2022 | $188,160 | -25.3% | 168,000 | -24.7% | 0.00% | 0.0% |
| Q3 2022 | $252,000 | -52.6% | 223,000 | -38.4% | 0.00% | -50.0% |
| Q2 2022 | $532,000 | -64.7% | 361,900 | -45.0% | 0.00% | -50.0% |
| Q1 2022 | $1,508,000 | -37.7% | 658,300 | -25.2% | 0.00% | -33.3% |
| Q4 2021 | $2,420,000 | -60.1% | 879,900 | -13.0% | 0.01% | -62.5% |
| Q3 2021 | $6,068,000 | +25.9% | 1,011,400 | +2.2% | 0.02% | +23.1% |
| Q2 2021 | $4,821,000 | +199.4% | 990,000 | +51.9% | 0.01% | +225.0% |
| Q1 2021 | $1,610,000 | +1083.8% | 651,800 | +1208.8% | 0.00% | – |
| Q4 2020 | $136,000 | -14.5% | 49,800 | -51.7% | 0.00% | – |
| Q3 2020 | $159,000 | +467.9% | 103,100 | +415.5% | 0.00% | – |
| Q1 2019 | $28,000 | -77.0% | 20,000 | +75.4% | 0.00% | – |
| Q1 2018 | $122,000 | – | 11,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |